JRNYS Review

JRNYS: a GLP-1 membership built around brand-name drugs and your insurance

Most telehealth weight-loss programs here are built on compounded medication, because that's how they keep prices low for cash-paying patients. JRNYS mostly goes the other direction. It's a membership-and-coaching service designed to get you the FDA-approved branded drugs (Wegovy, Ozempic, Mounjaro and Zepbound) and to lean on your commercial insurance to pay for them. If you have decent coverage, you pay JRNYS a monthly membership for the medical care and support, and your insurer covers most of the drug. For cash payers there's now one compounded option too, covered below.

How the two-part pricing actually works

This is the most important thing to understand before you sign up. On the brand-name route, JRNYS splits your cost into two buckets that most competitors bundle together.

• The membership runs $89 to $169 a month, depending on how much one-on-one coach support you want. The FAQ says it covers your medical visits, daily monitoring, coaching and member-only content. A code on the site takes 50% off the first month.
• The medication is billed separately by your pharmacy or insurer. JRNYS says most commercially insured members should pay no more than $25 a month for a GLP-1 after any deductible. Self-pay brand prices aren't published and are confirmed after your consult.

So the membership price is only part of the picture, because your true monthly cost is membership plus medication, and the medication side swings with your coverage. The category median we track is $179 a month. An insured member on the basic tier can land well under that, while a self-pay brand patient could land far above it.

How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 508 GLP-1 providers we track.

Mostly brand-name, with one compounded cash option

JRNYS prescribes the name-brand pens: semaglutide as Ozempic or Wegovy and tirzepatide as Mounjaro or Zepbound. It sends the prescription and helps with prior authorizations. It does not bill insurance itself, so your pharmacy handles the claim, and on the brand route you get the exact manufacturer product with no formulation questions.

The newer addition is a compounded tirzepatide microdose listed from $216 a month. It's cash pay and ships to your door. Compounded drugs are not FDA-approved finished products, so it carries the usual trade-offs of that route, and the site doesn't say whether the membership fee is charged on top of that price. Ask about that before you choose it.

Coaching is built into the membership

The tiers are priced by how much one-on-one coach support you get, and the FAQ says even the base price includes coaching. Some pages also describe coaching and meal delivery as optional extras, so confirm what your tier actually includes before you pay. Members also get provider review within 24 hours and unlimited messaging with their provider. Many programs skip human coaching entirely in favor of app nudges, so that's a real differentiator.

Medical oversight: a named, credentialed CMO

Care is led by founder and Chief Medical Officer Dr. Henry Legere. His background includes UC Berkeley, medical training at Columbia, and a Harvard fellowship. A named physician leader is a meaningful trust signal in a space full of faceless intake forms. JRNYS has no FDA warning letters on file, but there is one soft spot: the star ratings shown on the site differ from page to page and don't name a review platform, so we don't lean on them.

Who should choose JRNYS — and who should skip it

Choose it if you have solid commercial insurance and specifically want brand-name Wegovy, Ozempic, Mounjaro or Zepbound rather than a compound. For that person, the insured medication cap plus included coaching can make this one of the lower true-cost ways to be on a branded GLP-1.

Pause if you're paying cash for a brand-name drug. That price isn't disclosed until after your consult, and branded pens are pricey without coverage. Read the cancellation terms too, because you need to cancel at least 7 days before your next billing date or you're charged for the next cycle. The $89 initial telehealth fee is non-refundable once a provider reviews your profile. JRNYS also doesn't publish which states it serves, and support is by email only.

Bottom line

JRNYS is a coverage-first, brand-first GLP-1 program with included coaching and a credentialed medical lead. It's a strong fit for insured patients who want the real manufacturer drug at a capped copay. Cash payers now have a compounded tirzepatide option from $216, but should ask whether membership is added on top. Confirm your state eligibility before you start. For how we weigh transparency, oversight, and value, see our scoring methodology.

If you're weighing alternatives, Oak ($200/month) and MadeMed ($219/month) are among the closest options we track to JRNYS.